Hand-foot syndrome (palmar-plantar erythrodysaesthesia);Das hand-fuss-syndrom (palmar-plantare erythrodysasthesie)

Schweizerische Medizinische Wochenschrift

Volumn 130, Issue 40, 2000, Pages 1413-1416

  Salzberg, M ^a   Herrmann, R ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Continuous 5 FU therapy; Hand foot syndrome; Palmar plantar erythema; Skin lesion

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; HYDROXYUREA; IRINOTECAN; LIPOSOMAL DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; NAVELBINE; OXALIPLATIN; PYRIDOXINE; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CLINICAL FEATURE; DISEASE SEVERITY; DYSESTHESIA; ERYTHEMA; HAND FOOT SYNDROME; HUMAN; MEDICAL LITERATURE; PALMAR PLANTAR ERYTHRODYSESTHESIA; PATHOGENESIS; QUALITY OF LIFE; REVIEW;

ANTINEOPLASTIC AGENTS; ENGLISH ABSTRACT; ERYTHEMA; FOOT; HAND; HUMAN; MEDLINE; PARESTHESIA; SYNDROME;

EID: 0034619049     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Schedule-selection biochemical modulation of 5-fluorouracil: A phase II study in advanced colorectal cancer
2. A simplified regimen of weekly high-dose 5-fluorouracil and leucovorin as a 24-hour infusion in patients with advanced colorectal carcinoma
3. Toxicity of fluorouracil in patients with advanced colorectal cancer effect of administration schedule and prognostic factors
4. UFT and leucovorin: A review of its clinical development and therapeutic potential in the oral treatment of cancer
5. Uracil-Ftorafur: An oral fluorpyrimidine active in colorectal cancer
6. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
7. Hand-foot syndrome following prolonged infusion of high-dose of vinorelbine
8. Hand-foot syndrome following prolonged infusion of high-dose vinorelbine - Author reply
9. Irinotecan is an active agent in untreated patients with metastatic colorectal cancer
10. Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: A randomized, double-blind clinical trial using a canine model
11. Hand-foot syndrome in sickle cell disease
12. Salmonella osteomyelitis in sickle cell disease children in the east end of London
13. The role of dihydropyrimidine dehydrogenase (DPD) modulation in 5-FU pharmacology
14. Pyridoxine (B6) and amelioration of hand/foot syndrome
15. Palmar-plantar erythema associated with combination chemotherapy
16. Erythematous eruption of the palms and the soles associated with mitotane therapy
17. Chemotherapy-associated palmar plantar erythrodysesthesia syndrome
18. 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment